Vacuum device label extended for use during recovery from RP
November 2nd 2006Timm Medical said the FDA has allowed the company to extend the labeling of its Osbon ErecAid device for use in creating and maintaining erections by providing arterial blood to the penis during recovery from radical prostatectomy.
Immunotherapy shown to lower mortality risk in patients with prostate Ca
November 2nd 2006New explanatory analyses of a phase III study support earlier results observed with treatment using the investigational active cellular immunotherapy sipuleucel-T (Provenge) in men with advanced androgen-independent prostate cancer, researchers reported at the Prostate Cancer Foundation's annual scientific retreat in Scottsdale, AZ.
Genetic variations help target location of prostate cancer genes
November 2nd 2006The National Cancer Institute has released new data from the Cancer Genetic Markers of Susceptibility study on prostate cancer that may help identify genetic factors that influence the disease and will be integral to the discovery and development of new targeted therapies.
NSAID alleviates pain of PNL in select patients
November 1st 2006Cleveland-Intravenous ketorolac tromethamine is safe and appears to be effective at alleviating pain following percutaneous nephrolithotomy (PNL) procedures in properly selected patients, according to a study from the Methodist Hospital Institute for Kidney Stone Disease and Indiana University School of Medicine, Indianapolis.
Crossing vessel transposition optional in pyeloplasty
November 1st 2006Cleveland-Routine transposition of an anterior crossing vessel during laparoscopic pyeloplasty may be unnecessary, appears to depend on the surgeon's intraoperative subjective assessment of its obstructive nature, and seems to occur more often when a transperitoneal approach is used, Cleveland Clinic investigators reported.
New data may add to concerns over SWL, diabetes risk
November 1st 2006Cleveland-A Mayo Clinic study published earlier this year raised more than a few eyebrows when its authors concluded that treatment of renal stones with shockwave lithotripsy appears to heighten the risk of diabetes mellitus and hypertension. More recently, researchers from Northwestern University reported a similar finding in patients with pancreatic stones-that SWL used in these patients may be associated with an increased risk of diabetes.
Staged lithotripsy may be viable alternative to PCNL
November 1st 2006Cleveland-A staged approach to endoscopic lithotripsy may be a reasonable treatment option in patients with large renal stones who are not ideal candidates for the gold standard of percutaneous nephrolithotomy (PCNL), researchers at the University of Pittsburgh Medical Center reported. Their technique, known as staged retrograde endoscopic lithotripsy (SREL), has a slightly lower success rate than PCNL does, but it is less invasive and associated with fewer complications.
URS for renal stones: Data show changing trends in use
November 1st 2006Cleveland-With the growing acceptance of flexible ureteroscopy at academic centers, this endoscopic technique as a treatment for renal stones has made fewer inroads into the practices of community urologists, data from a large U.S. inpatient database indicate. The reasons for the procedure's apparent lack of popularity in the community, at least in the inpatient setting, are unclear.
Larger stone volume equals more work, similar outcomes
November 1st 2006Cleveland-The size and volume of upper-urinary-tract calculi do not necessarily predict outcomes of ureteroscopic lithotripsy, but stones of larger size and volume require significantly more time and effort to clear, according to a group of urologists from St. Paul, MN.
Search for diet, stone info reveals a tangled Web
November 1st 2006Cleveland-Dean G. Assimos, MD, professor of urology at the Wake Forest School of Medicine, Winston-Salem, NC, asked a simple question here at the World Congress of Endourology: "Is the Internet a reliable source of information for dietary recommendations for stone formers?"
Is cola-stone formation link just an urban legend?
November 1st 2006Cleveland-Urologists at Emory University, Atlanta, may or may not have slain an urban myth, but at the very least, the team has given it a sound kick. Cola in moderation does not change urine chemistries significantly, and therefore does not appear to raise the risk of forming stones, the team concluded after comparing cola to deionized water in a randomized, prospective pilot study.
Urine markers in obese patients signal stone risk
November 1st 2006Cleveland-A Harvard Medical School study published last year in JAMA (2005; 293:455-62) established a link between obesity and kidney stone formation. Now researchers at the University of Minnesota have taken the next step with a study showing that obese men and women have at least one, if not more, urine abnormalities that increase their risk of stone formation.
Patient BMI shows little impact on PCNL outcomes
November 1st 2006Cleveland-There is a commonly held view that obese patients tend to present greater surgical challenges and have more complications after percutaneous nephrolithotomy. Researchers from Albert Einstein College of Medicine in New York have challenged that belief.
NSAID alleviates pain of PNL in select patients
November 1st 2006Cleveland-Intravenous ketorolac tromethamine is safe and appears to be effective at alleviating pain following percutaneous nephrolithotomy (PNL) procedures in properly selected patients, according to a study from the Methodist Hospital Institute for Kidney Stone Disease and Indiana University School of Medicine, Indianapolis.
Sexual compulsive behaviors, ED drug misuse linked
November 1st 2006Boston-A study investigating a treatment sample of men diagnosed with sexual compulsivity suggests that prescription and non-prescription use of phosphodiesterase type-5 inhibitors is common in that population. This finding should alert physicians who prescribe medications for erectile dysfunction to maintain an index of patients with a suspected sexual compulsivity problem and to be attentive to clues of potential drug misuse, according to the researchers.
RCC 'disconnect': Both treatment, mortality rising
November 1st 2006Ann Arbor, MI-Results of a study from the University of Michigan here provide further evidence that the incidence of kidney cancer and the rate of surgical treatment are both on the rise. However, those trends are primarily accounted for by the identification and management of small, presumably curable renal masses (?4 cm). Meanwhile, mortality rates in kidney cancer patients have also been increasing, driven by worsening outcomes of patients with the largest tumors (>7 cm).
Council warns of strong ties between TCE, kidney cancer
November 1st 2006Washington-Trichloroethylene (TCE) is a chlorinated hydrocarbon once commonly used as a degreasing agent in industrial settings. The nonflammable, colorless fluid may also be found as an ingredient in adhesives, paint removers, typewriter correction fluids, and spot removers. Although a clear-cut link between TCE and cancer has yet to be established, the chemical is the subject of a recent report calling for research on how it causes cancer and other adverse health effects.
Tubeless PNL: Studies address ideal stents, candidates
November 1st 2006Cleveland-Two studies from the University of Minnesota and one from the University of Tennessee presented at the World Congress of Endourology tackled three important questions raised by the use of nephrostomy tubes: Which configuration best minimizes pain? How small can the tube be and remain effective? When can a nephrostomy tube be abandoned altogether?
Rehab is key to restoring post-RP erectile dysfunction
November 1st 2006The return and quality of sexual function is a major concern for men undergoing radical prostatectomy. New research on the etiology of post-prostatectomy erectile dysfunction is shaping new rehabilitation strategies for prostatectomy patients, according to John P. Mulhall, MD, who discusses current and future rehabilitation strategies and his own approach to post-prostatectomy ED in this exclusive interview.